Claudia Syueping Crowell, MD

Claudia Syueping Crowell, MD

Infectious Disease Research

On staff since December 2012

"Taking care of children and their families is the most rewarding aspect of my job. Providing medical care for a child is really a team endeavor, one that, most importantly, includes the child and his/her family, and my goal in every patient encounter is to partner with patients and their families to develop the best management plan for them."

  • Claudia S. Crowell, MD, MPH joined the Division of Pediatric Infectious Diseases in 2012. She earned a medical doctorate degree with honors from the University of Washington in 2006, followed by pediatric residency and pediatric infectious disease fellowship training at Northwestern University. Dr. Crowells primary research interests are management of pediatric HIV, and prevention and treatment of complications of HIV and its treatment.

    Dr. Crowell is co-investigator of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) unit at Seattle Children's Research Institute. She is also involved in several international studies examining the neurodevelopmental outcomes of HIV-infected children and studying potential interventions to improve long-term neurodevelopment in these children. Dr. Crowell's clinical time is split between inpatient Infectious Diseases consultations and the outpatient Infectious Diseases clinic. She also serves as a consultant to the Seattle Children's Hospital Clinical Effectiveness program, assisting with the development and implementation of clinical pathways of care for patients at Seattle Children's Hospital.

  • Manuscripts in Refereed Journals

    • Crowell CS, Huo Y, Tassiopoulos K, Malee KM, Yogev R, Hazra R, Rutstein RM, Nichols SL, Smith RA, Muller WJ for the IMPAACT 219C Study Team and the Pediatric HIV/AIDS Cohort Study
      Early Viral Suppression Improves Neurocognitive Outcomes in HIV-infected Children.
      25686678 AIDS, 2015 Jan. 28 : 29(3)295-304 PMCID:PMCID: PMC4332557
    • Pintye J, Saltzman BS, Wolf ER, Crowell CS
      Risk Factors for Late-Onset Group B Streptococcal Disease: A Case-Control Study
      J Ped Inf Dis Soc, 2015
    • Crowell CS, Malee KM, Yogev R, Muller WJ
      Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.
      24806816 Reviews in Medical Virology, 2014 Sept. : 24(5)316
    • Crowell C, Kiruga JM, Figaji A, Simat K, Padayachy L, Pillay K and Yogev R
      Neuroschistosomiasis due to Shistosoma haematobium presenting as spinal cord neoplasm.
      21734619 The Pediatric Infectious Disease Journal, 2011 Nov. : 30(11)1006-1008
    • Crowell CS, Stamos JK
      Evaluation of Fever after International Travel.
      21210599 Pediatric Annals, 2011 Jan. : 40(1)40-45
    • Beck IA, Crowell C, Kittoe R, Bredell H, Machaba M, Willamson C, Janssens W, Jallow S, van der Groen G, Shao Y, Jacob M, Samuel MN, de Rivera IL, Ngo-Giang-Huong N, Cassol S, Alemnji G, Frenkel LM.
      Optimization of the Oligonucleotide Ligation Assay, a Rapid and Inexpensive Test for Detection of HIV-1 Drug-Resistance Mutations, for Non-North American Variants.
      18614915 Journal of Acquired Immune Deficiency Syndromes, 2008 Aug. 1 : 48(4)418-427 PMCID:PMCID: PMC2583356
    • Crowell CS, Melin-Aldana H, Tan TQ
      Fever, Rash and Hepatic Dysfunction in a 3 year-old Child: A Case Report.
      18509155 Clinical Pediatrics, 2008 June : 47(5)517-520
    • Chang DC, Grant GB, ODonnell K, Wannemuehler KA, Noble-Wang J, Rao CY, Jacobson LM, Crowell CS, Sneed RS, Lewis FMT, Schaffzin JK, Kainer MA, Genese CA, Alfonso EC, Jones DB, Srinivasan A, Fridkin SK, Park BJ
      Multistate Outbreak of Fusarium Keratitis Associated With Use of a Contact Lens Solution.
      16926355 JAMA, 2006 Aug. 23 : 296(8)953-963

  • Presentations Title Event Location Date
    High rates of baseline NNRTI-resistance and virologic failure among ART nave HIV-1 infected children in Mali International AIDS Society Vancouver, Canada July 19, 2015 - July 22, 2015
    Better growth at entry to ART Is associated with higher neurodevelopmental function at ART and improved post-ART recovery of function in Kenyan children International AIDS Society Vancouver, Canada July 19, 2015 - July 22, 2015
    Risk Factors for Late-Onset Group B Streptococcal Disease: A Case-Control Study Pediatric Academic Societies Vancouver, BC May 2014
    Early Viral Suppression Improves Neurocognitive Outcomes in HIV-infected Children Conference on Retroviruses and Opportunistic Infections Boston, MA March 3, 2014 - March 6, 2014
    Pediatric Antiretroviral Drug Toxicities MDH/Harvard PEPFAR Advanced Antiretroviral Therapy Training Dar Es Salaam, Tanz July 2011
    Pediatric HIV Opportunistic Infections MDH/Harvard PEPFAR Advanced Antiretroviral Therapy Training Dar Es Salaam, Tanzania July 2011
  • Grant Title Grantor Amount Award Date
    Improving Neurodevelopmental Outcomes of HIV-Infected Children in Kenya Seattle Childrens Hospital July 1, 2014 - June 30, 2016
    A Pilot Study of the Effect of the Mediational Intervention of Sensitizing Caregivers (MISC) on Neurodevelopment in HIV-infected Children in Kenya Seattle Childrens Hospital Oct. 1, 2013 - March 31, 2015
    Resistance in HIV-1 non-subtype B infected children failing first-line antiretroviral therapy. Thrasher Early Career Award June 2011 - Aug. 2013
    Phenotypic and Genotypic Resistance in HIV-1 non-Subtype B in Children Failing First-Line Antiretroviral Therapy Colman Family Grant July 2010 - June 2012
    International and Domestic Pediatric and Maternal HIV Studies Coordinating Center (Westat) Clinical trials site to advance the interruption of mother to infant HIV-1 transmission, and improve prevention and treatment of HIV-1 infection for children a NIH


Medical/Professional School

University of Washington, Seattle
University of Washington School of Public Health, Seattle


Pediatrics, Northwestern University Feinberg School of Medicine, Chicago


Infectious Disease, Northwestern University Feinberg School of Medicine, Chicago

Research Description

Pediatric HIV, focusing on prevention, treatment efficacy and clinical outcomes